FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

414805007: natalizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2531793014 Natalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2535349018 Natalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
647601000241111 natalizumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
827271000172117 natalizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Natalizumab (substance) est un(e) (attribut) Immunosuppressant (substance) true Inferred relationship Some
Natalizumab (substance) est un(e) (attribut) Alpha-4 integrin receptor antagonist true Inferred relationship Some
Natalizumab (substance) est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
Natalizumab (substance) est un(e) (attribut) anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Natalizumab (substance) est un(e) (attribut) Inflammatory bowel disease agent (substance) false Inferred relationship Some
Natalizumab (substance) Has disposition (attribute) Alpha-4 integrin receptor antagonist (disposition) true Inferred relationship Some
Natalizumab (substance) Has disposition (attribute) Murine-human monoclonal immunoglobulin G antibody (disposition) false Inferred relationship Some
Natalizumab (substance) est un(e) (attribut) Gastrointestinal agent (substance) true Inferred relationship Some
Natalizumab (substance) Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Natalizumab-containing product in parenteral dose form a pour principe actif (attribut) True Natalizumab (substance) Inferred relationship Some 1
Product containing only natalizumab (medicinal product) a pour principe actif (attribut) True Natalizumab (substance) Inferred relationship Some 1
Product containing only natalizumab in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Natalizumab (substance) Inferred relationship Some 1
Natalizumab 20 mg/mL solution for injection Has basis of strength substance (attribute) True Natalizumab (substance) Inferred relationship Some 1
Natalizumab 20 mg/mL solution for injection Has precise active ingredient True Natalizumab (substance) Inferred relationship Some 1
Natalizumab therapy substance utilisée (attribut) True Natalizumab (substance) Inferred relationship Some 1
Product containing natalizumab (medicinal product) a pour principe actif (attribut) True Natalizumab (substance) Inferred relationship Some 1
Natalizumab 300mg injection solution 15mL vial (product) a pour principe actif (attribut) False Natalizumab (substance) Inferred relationship Some
Natalizumab 300 mg/15 mL solution for injection vial Has precise active ingredient False Natalizumab (substance) Inferred relationship Some 1
Natalizumab 300 mg/15 mL solution for injection vial Has basis of strength substance (attribute) False Natalizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start